<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: The increased use of human growth hormone (hGH) in numbers of children rise questions concerning the safety of GH replacement therapy (GHRT) </plain></SENT>
<SENT sid="1" pm="."><plain>Adverse effects of hGH treatment (<z:e sem="disease" ids="C0033845" disease_type="Disease or Syndrome" abbrv="">pseudotumor cerebri</z:e>, <z:e sem="disease" ids="C0030353" disease_type="Disease or Syndrome" abbrv="">papilloedema</z:e>, <z:chebi fb="46" ids="15035">retinal</z:chebi> changes mimicking diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo>, neovascularization) have been reported in some papers </plain></SENT>
<SENT sid="2" pm="."><plain>PURPOSE: The aim of this study was to evaluate the influence of hGH therapy on the organ of vision </plain></SENT>
<SENT sid="3" pm="."><plain>MATERIAL AND METHODS: 10 girls with <z:e sem="disease" ids="C0041408" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Turner's syndrome</z:e> aged 12-16 years (mean 13.8+/-1.69) and 20 patients with somatotropic <z:mp ids='MP_0003348'>pituitary insufficiency</z:mp> aged 7-18 years (mean 12.98+/-2.81) were studied </plain></SENT>
<SENT sid="4" pm="."><plain>The mean duration of GHRT in patients with <z:e sem="disease" ids="C0041408" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Turner's syndrome</z:e> was 3.05+/-1.42 years (from 1 year to 5 year), in patients with somatotropic <z:mp ids='MP_0003348'>pituitary insufficiency</z:mp> was 2.45+/-2.32 years (from 8 months to 10 years) </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients underwent ophthalmic examination, including contrast sensitivity, direct and indirect ophthalmoscopy and <z:chebi fb="0" ids="31624">fluorescein</z:chebi> angiography </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: <z:hpo ids='HP_0000001'>All</z:hpo> parts of ophthalmological examination were <z:mpath ids='MPATH_458'>normal</z:mpath> </plain></SENT>
<SENT sid="7" pm="."><plain>There were no abnormalities in <z:chebi fb="0" ids="31624">fluorescein</z:chebi> angiography </plain></SENT>
<SENT sid="8" pm="."><plain>Contrast sensitivity was correct in <z:hpo ids='HP_0000001'>all</z:hpo> eyes </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: There was no harmful effect of GHRT on the retina and optic nerve in young patients </plain></SENT>
<SENT sid="10" pm="."><plain>The follow-up and ophthalmologic evaluation is advisable </plain></SENT>
</text></document>